While cancer continues to be
a major health problem in developed countries, emerging
regions actually account for a disproportionate number
of cases. Eighty five percent of the world’s population
live in emerging regions however changing lifestyles,
the so called of ‘westernisation’ of diets, increased
use of tobacco and poor health resources contribute to
increased incidences of cancer with a high mortality
ratio.
Whilst this presents these countries with increasing
problems it does position emerging regions as suitable
targets within which to conduct clinical research in
oncology as well as the opportunity to target specific
countries or even regions different forms of cancer are
particularly prevalent.
Increasing the number and quality of clinical research
trials in emerging regions should yield important new
data about the epidemiology and biology of cancers that
has not previously been available. However, although
there are numerous benefits actually identifying
countries or regions, securing and working with local
investigators and adherence to local regulatory are just
some of the many challenges faced when planning and
executing oncology clinical trials in emerging regions.
Through a series of keynote regional presentations, case
studies and interactive panel discussions
the ‘Oncology Clinical Trials in Emerging
Regions’ (OCTER) conference, now in it's 5th year, will
examine the current role that emerging regions play in
conducting oncology clinical trials focusing on the
operational, regulatory and logistical challenges and
how is the likely to develop in the future as emerging
regions become more developed.
Topics will include –
Designing a patient and
recruitment strategy plan
Anticipating problems in
conducting oncology clinical trials and implementing
risk strategy
Selecting regions for specific
cancer trials
Assessing the qualifications of a
site and prioritization
Case studies and first hand
experience of running oncology trials in Latin America
and Asia Pacific
Regulatory variations of emerging
markets when conducting oncology trials
Selecting and engaging with
investigators in emerging regions
Specific logistical challenges
when conducting oncology clinical trials in emerging
regions
Managing data collection in
emerging regions
Ethics committees and their role
in developing markets
Copyright: Global Engage Ltd.
Registered in England. No: 6950636
